Marshall Wace’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.2M	Sell	628,075 -396,850	-39%	-$35.1M	0.07%	271
2025 Q4	$89.5M	Sell	1,024,925 -60,639	-6%	-$4.96M	0.09%	190
2025 Q3	$72.1M	Buy	+1,085,564	New	+$61.7M	0.08%	238
2025 Q1	–	Sell	-19,716	Closed	-$761K	–	3027
2024 Q4	$761K	Sell	19,716 -295,657	-94%	-$12.9M	﹤0.01%	1864
2024 Q3	$14.2M	Sell	315,373 -256,804	-45%	-$10.4M	0.02%	627
2024 Q2	$19.8M	Sell	572,177 -404,716	-41%	-$11.9M	0.03%	502
2024 Q1	$28.3M	Buy	976,893 +834,423	+586%	+$22.7M	0.05%	397
2023 Q4	$3.27M	Buy	142,470 +120,723	+555%	+$2.11M	0.01%	1052
2023 Q3	$363K	Sell	21,747 -142,753	-87%	-$2.77M	﹤0.01%	1817
2023 Q2	$4.54M	Sell	164,500 -1,201,580	-88%	-$30.1M	0.01%	1058
2023 Q1	$31.4M	Sell	1,366,080 -88,366	-6%	-$1.48M	0.08%	313
2022 Q4	$15.9M	Buy	1,454,446 +639,720	+79%	+$5.4M	0.04%	564
2022 Q3	$6.87M	Buy	814,726 +350,669	+76%	+$3.32M	0.02%	1154
2022 Q2	$3.67M	Buy	+464,057	New	+$5.61M	0.01%	1575
2021 Q2	–	Sell	-86,691	Closed	-$2.25M	–	3036
2021 Q1	$2.25M	Sell	86,691 -30,103	-26%	-$762K	0.01%	1265
2020 Q4	$2.35M	Buy	+116,794	New	+$2.51M	0.01%	883
2019 Q3	–	Sell	-17,799	Closed	-$216K	–	1890
2019 Q2	$216K	Buy	+17,799	New	+$197K	﹤0.01%	1235